Taken together, these data suggest that TCN treatment regulates lipid metabolism via LKB1-AMPK signaling pathway and promotes β-oxidation by PPARα; hence, TCN may have potential remedy in the prevention and treatment of obesity. This evidence concerns the gene STK11 and obesity due to melanocortin 4 receptor deficiency.